Ali Sakhdari

Dr. Ali Sakhdari

Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2010 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
BVBahareh Vali
Bahareh Vali
RJR. Brad Jones
R. Brad Jones
Ali SakhdariAli Sakhdari
Ali Sakhdari
PSPrameet M. Sheth
Prameet M. Sheth
KCKiera Clayton
Kiera Clayton
MOMario A. Ostrowski
Mario A. Ostrowski
Co‐infection of HCV with HIV has been associated with more rapid progression of HCV‐related disease. HCV‐specific T‐cell immune responses, which are essential for disease control, are attenuated in co‐infection with HIV. T‐cell exhaustion has recently been implicated in the deficient control of chronic viral infections. In the current study, we investigated the role of programmed death‐1 (PD‐1) and T‐cell immunoglobulin and mucin domain‐containing molecule‐3 (Tim‐3) expression in T‐cell exhaustion during HCV/HIV co‐infection. We show that in HCV/HIV co‐infection, both total and HCV‐specific T cells co‐express Tim‐3 and PD‐1 in significantly higher frequencies, compared with HCV mono‐infection. Co‐expression of these two markers on HCV‐specific CD8+ T cells positively correlated with a clinical parameter of liver disease progression. HCV‐specific CD8+ T cells showed greater frequencies of Tim‐3/PD‐1 co‐expression than HIV‐specific CD8+ T cells, which may indicate a greater degree of exhaustion in the former. Blocking Tim‐3 or PD‐1 pathways restored both HIV‐ and HCV‐specific CD8+ T‐cell expansion in the blood of co‐infected individuals. These data demonstrate that co‐expression of Tim‐3 and PD‐1 may play a significant role in HCV‐specific T‐cell dysfunction, especially in the setting of HIV co‐infection.

15 April 2012 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SMShariq Mujib
Shariq Mujib
RJR Brad Jones
R Brad Jones
CLCalvin Lo
Calvin Lo
NANasra Aidarus
Nasra Aidarus
KCKiera Clayton
Kiera Clayton
MOMario A Ostrowski
Mario A Ostrowski
The activity of IDO that catalyzes the degradation of tryptophan (Trp) into kynurenine (Kyn) increases after diseases caused by different infectious agents. Previously, we demonstrated that IDO has an important immunomodulatory function in immune-related diseases. However, the pathophysiological role of IDO following acute viral infection is not fully understood. To investigate the role of IDO in the l-Trp–Kyn pathway during acute viral myocarditis, mice were infected with encephalomyocarditis virus, which induces acute myocarditis. We used IDO-deficient (IDO−/−) mice and mice treated with 1-methyl-d,l-Trp (1-MT), an inhibitor of IDO, to study the importance of Trp–Kyn pathway metabolites. Postinfection with encephalomyocarditis virus infection, the serum levels of Kyn increased, whereas those of Trp decreased, and IDO activity increased in the spleen and heart. The survival rate of IDO−/− or 1-MT–treated mice was significantly greater than that of IDO+/+ mice. Indeed, the viral load was suppressed in the IDO−/− or 1-MT–treated mice. Furthermore, the levels of type I IFNs in IDO−/− mice and IDO−/− bone marrow-transplanted IDO+/+ mice were significantly higher than those in IDO+/+ mice, and treatment of IDO−/− mice with Kyn metabolites eliminated the effects of IDO−/− on the improved survival rates. These results suggest that IDO has an important role in acute viral myocarditis. Specifically, IDO increases the accumulation of Kyn pathway metabolites, which suppress type I IFNs production and enhance viral replication. We concluded that inhibition of the Trp–Kyn pathway ameliorates acute viral myocarditis.

1 July 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FYFeng Yun Yue
Feng Yun Yue
CLCalvin Lo
Calvin Lo
Ali SakhdariAli Sakhdari
Ali Sakhdari
ELErika Yue Lee
Erika Yue Lee
CKColin M. Kovacs
Colin M. Kovacs
MOMario A Ostrowski
Mario A Ostrowski
We examined the role of CD4+ T cell IL-21 production in viral control of HIV infection. HIV-infected individuals had greater circulating IL-21–producing CD4+ T cells in blood compared with uninfected volunteers. HIV-specific IL-21–producing CD4+ T cells were detected in blood during untreated acute and chronic HIV infection, and elevated frequencies of these cells correlated with relative viral control. These cells had an effector memory or end effector phenotype and expressed CXCR5. HIV-specific CD8+ T cells exhibited high levels of IL-21R, indicating sensitivity to IL-21. Low or aviremic long-term nonprogressors, however, showed absent or low HIV-specific IL-21 CD4+ T cells, but more easily detectable HIV-specific IL-2–producing CD4+ T cells, suggesting changing requirements for particular γ-chain cytokines depending on Ag abundance. Thus, IL-21–producing CD4+ T cells are induced in viremic HIV infection and likely contribute to viral control by affecting CD8+ T cell maintenance.

5 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Ali SakhdariAli Sakhdari
Ali Sakhdari
SMShariq Mujib
Shariq Mujib
BVBahareh Vali
Bahareh Vali
FYFeng Yun Yue
Feng Yun Yue
SMSonya MacParland
Sonya MacParland
MOMario A. Ostrowski
Mario A. Ostrowski
Cytotoxic CD8+ T cells (CTLs) contain virus infections through the release of granules containing both perforin and granzymes. T cell ‘exhaustion’ is a hallmark of chronic persistent viral infections including HIV. The inhibitory regulatory molecule, T cell Immunoglobulin and Mucin domain containing 3 (Tim-3) is induced on HIV-specific T cells in chronic progressive infection. These Tim-3 expressing T cells are dysfunctional in terms of their capacities to proliferate or to produce cytokines. In this study, we evaluated the effect of Tim-3 expression on the cytotoxic capabilities of CD8+ T cells in the context of HIV infection. We investigated the cytotoxic capacity of Tim-3 expressing T cells by examining 1) the ability of Tim-3+ CD8+ T cells to make perforin and 2) the direct ability of Tim-3+ CD8+ T cells to kill autologous HIV infected CD4+ target cells. Surprisingly, Tim-3+ CD8+ T cells maintain higher levels of perforin, which was mainly in a granule-associated (stored) conformation, as well as express high levels of T-bet. However, these cells were also defective in their ability to degranulate. Blocking the Tim-3 signalling pathway enhanced the cytotoxic capabilities of HIV specific CD8+ T cells from chronic progressors by increasing; a) their degranulation capacity, b) their ability to release perforin, c) their ability to target activated granzyme B to HIV antigen expressing CD4+ T cells and d) their ability to suppress HIV infection of CD4+ T cells. In this latter effect, blocking the Tim-3 pathway enhances the cytotoxcity of CD8+ T cells from chronic progressors to the level very close to that of T cells from viral controllers. Thus, the Tim-3 receptor, in addition to acting as a terminator for cytokine producing and proliferative functions of CTLs, can also down-regulate the CD8+ T cell cytotoxic function through inhibition of degranulation and perforin and granzyme secretion.

29 April 2016 in Histopathology
Verified
Journal Article
Closed access
PDF file
MKMichal Kamionek
Michal Kamionek
PMParnian Ahmadi Moghaddam
Parnian Ahmadi Moghaddam
Ali SakhdariAli Sakhdari
Ali Sakhdari
AKAlexandra E Kovach
Alexandra E Kovach
MWMatthew Welch
Matthew Welch
LHLloyd M Hutchinson
Lloyd M Hutchinson

1 August 2019 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
Ali SakhdariAli Sakhdari
Ali Sakhdari
COChi Young Ok
Chi Young Ok
KPKeyur P. Patel
Keyur P. Patel
RKRashmi Kanagal-Shamanna
Rashmi Kanagal-Shamanna
CYC. Cameron Yin
C. Cameron Yin
SLSanam Loghavi
Sanam Loghavi